204 related articles for article (PubMed ID: 11145895)
41. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
[TBL] [Abstract][Full Text] [Related]
42. HIV gene therapy using RNA virus systems.
Hayafune M; Miyano-Kurosaki N; Kusunoki A; Mouri Y; Takaku H
Nucleic Acids Symp Ser (Oxf); 2006; (50):79-80. PubMed ID: 17150826
[TBL] [Abstract][Full Text] [Related]
43. Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus.
Berkowitz R; Ilves H; Lin WY; Eckert K; Coward A; Tamaki S; Veres G; Plavec I
J Virol; 2001 Apr; 75(7):3371-82. PubMed ID: 11238863
[TBL] [Abstract][Full Text] [Related]
44. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells.
Parveen Z; Krupetsky A; Engelstädter M; Cichutek K; Pomerantz RJ; Dornburg R
Nat Biotechnol; 2000 Jun; 18(6):623-9. PubMed ID: 10835599
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a membrane-associated protein implicated in visna virus binding and infection.
Bruett L; Barber SA; Clements JE
Virology; 2000 May; 271(1):132-41. PubMed ID: 10814578
[TBL] [Abstract][Full Text] [Related]
46. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
Arya SK; Zamani M; Kundra P
Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
[TBL] [Abstract][Full Text] [Related]
47. Molecular studies of visna virus gene expression: analysis of envelope gene expression in transgenic sheep.
Clements JE; Hu L; Lindstrom L; Powell A; Rexroad C; Zink MC
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):421-3. PubMed ID: 8882324
[No Abstract] [Full Text] [Related]
48. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.
Bruett L; Clements JE
J Virol; 2001 Dec; 75(23):11464-73. PubMed ID: 11689628
[TBL] [Abstract][Full Text] [Related]
49. [Visna and AIDS--various comparative aspects].
Georgsson G; Andrésdóttir V; Pálsson PA; Pétursson G
Nord Med; 1991; 106(4):112-5. PubMed ID: 1645467
[TBL] [Abstract][Full Text] [Related]
50. cis- and trans-acting transcriptional regulation of visna virus.
Hess JL; Clements JE; Narayan O
Science; 1985 Aug; 229(4712):482-5. PubMed ID: 2990051
[TBL] [Abstract][Full Text] [Related]
51. Two-step gene transfer using an adenoviral vector carrying the CD4 gene and human immunodeficiency viral vectors.
Miyake K; Tohyama T; Shimada T
Hum Gene Ther; 1996 Dec; 7(18):2281-6. PubMed ID: 8953319
[TBL] [Abstract][Full Text] [Related]
52. Visna virus dUTPase is dispensable for neuropathogenicity.
Pétursson G; Turelli P; Matthíasdóttir S; Georgsson G; Andrésson OS; Torsteinsdóttir S; Vigne R; Andrésdóttir V; Gunnarsson E; Agnarsdóttir G; Quérat G
J Virol; 1998 Feb; 72(2):1657-61. PubMed ID: 9445073
[TBL] [Abstract][Full Text] [Related]
53. Construction and characterization of an infectious molecular clone of maedi-visna virus that expresses green fluorescent protein.
Gudmundsdóttir HS; Olafsdóttir K; Franzdóttir SR; Andrésdóttir V
J Virol Methods; 2010 Sep; 168(1-2):98-102. PubMed ID: 20447418
[TBL] [Abstract][Full Text] [Related]
54. Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus.
Andrésson OS; Elser JE; Tobin GJ; Greenwood JD; Gonda MA; Georgsson G; Andrésdóttir V; Benediktsdóttir E; Carlsdóttir HM; Mäntylä EO
Virology; 1993 Mar; 193(1):89-105. PubMed ID: 8382414
[TBL] [Abstract][Full Text] [Related]
55. Transcription of visna virus during its lytic cycle: evidence for a sequential early and late gene expression.
Vigne R; Barban V; Quérat G; Mazarin V; Gourdou I; Sauze N
Virology; 1987 Nov; 161(1):218-27. PubMed ID: 2823463
[TBL] [Abstract][Full Text] [Related]
56. The establishment of a line of visna virus-producing human astrocytes (V-1181N1).
Macintyre EH; Wintersgill CJ; Thormar H
Med Res Eng; 1972; 11(4):7-13. PubMed ID: 4370460
[No Abstract] [Full Text] [Related]
57. Early events in infection of lymphoid tissue by a lentivirus, maedi-visna.
Blacklaws B; Bird P; McConnell I
Trends Microbiol; 1995 Nov; 3(11):434-40. PubMed ID: 8574517
[TBL] [Abstract][Full Text] [Related]
58. HIV and other lentivirus-based vectors.
Lever AM
Gene Ther; 1996 Jun; 3(6):470-1. PubMed ID: 8789794
[No Abstract] [Full Text] [Related]
59. Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.
Bjarnadottir H; Gudmundsson B; Gudnason J; Jonsson JJ
J Virol; 2006 Dec; 80(23):11743-55. PubMed ID: 16971429
[TBL] [Abstract][Full Text] [Related]
60. Characterization of a cDNA clone encoding the visna virus transactivating protein.
Davis JL; Clements JE
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):414-8. PubMed ID: 2536163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
